Merck & Co

Merck & Co Change in Working Capital

The Change in Working Capital of Merck & Co (MRK) as of Nov 2, 2026 is -6.98 B USD. In the previous year, Change in Working Capital was -3.67 B USD — a change of 90.24% (lower).

Change in Working Capital

-6.98 BUSD

YoY

90.24%

Last updated:

Change in Working Capital of Merck & Co is 2025 -6.98 B USD. Change in Working Capital of Merck & Co was 2024 -3.67 B USD. It decreases by 90.24% lower compared to the previous year.

The Merck & Co Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2018
-1.55 B USD
Jan 1, 2019
-2.07 B USD
Jan 1, 2020
-4.59 B USD
Jan 1, 2021
-3.84 B USD
Jan 1, 2022
-2.78 B USD
Jan 1, 2023
-2.21 B USD
Jan 1, 2024
-3.67 B USD
Jan 1, 2025
-6.98 B USD
The Merck & Co Change in Working Capital history
YEARChange in Working CapitalYoY
-6.98 BUSD+90.24%
-3.67 BUSD+66.30%
-2.21 BUSD-20.74%
-2.78 BUSD-27.53%
-3.84 BUSD-16.36%
-4.59 BUSD+122.06%
-2.07 BUSD+33.10%
-1.55 BUSD-69.07%
-5.02 BUSD+93.04%
-2.60 BUSD+870.52%
-268.00 MUSD-114.69%
1.82 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

Change in Working Capital of Merck & Co is -6.98 B USD in 2025.

Change in Working Capital of Merck & Co changed from -3.67 B USD to -6.98 B USD, representing a 90.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Merck & Co since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Merck & Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Merck & Co

All Key Metrics — Merck & Co